Product
Patsnap Eureka
For R&D, Patsnap Eureka makes reading and utilizing patents & technical documents easy.
Patsnap Eureka AIR
Designed for self-driven R&D workflows. Generate viable solutions, solve complex R&D challenges, empower your innovation with AI.
Patsnap Eureka Materials
Designed for material experts only. Revolutionize your material R&D, from search, analyze, to developing new materials.
Feature
TechResearch
Generate reliable direction feasibility study reports for your R&D in just a few steps.
TechSeek
Discover and master advanced knowledge NOW. Basics, ideas, possibilities, all at once.
TechMind
As an expert in R&D Theories, TechMind can generates customized viable solutions instantly.
TechRisk
Analyze your overall solution with one click, know your potential R&D risks in advance.
TechMonitor
Get weekly tech updates, stay abreast of the latest tech innovations and key insights.
Patents
Literature
Hiro is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
46 results about "Albuminuria" patented technology
Efficacy Topic
Property
Owner
Technical Advancement
Application Domain
Technology Topic
Technology Field Word
Patent Country/Region
Patent Type
Patent Status
Application Year
Inventor
Albuminuria is a pathological condition wherein the protein albumin is abnormally present in the urine. It is a type of proteinuria. Albumin is a major plasma protein (normally circulating in the blood); in healthy people, only trace amounts of it are present in urine, whereas larger amounts occur in the urine of patients with kidney disease. For a number of reasons, clinical terminology is changing to focus on albuminuria more than proteinuria.
Chinese medicinal composition for treating nephrotic syndrome and preparation thereof
The present invention relates to a Chinese medicine compound for curing nephropathy syndrome, which is made from milk veteh, dried orange peel, salvia, dangshen, largehead atractylode, cortex eucommiae, motherwort herb, gordon euryale seed, parasite scurrula, coix seed, Chinese yam, imperatae rhizome, poria skin, epimedium powder, slenderstyle acanthopanax bark, cooked rehmannia root and / or acceptable carriers in pharmacology. The present invention also relates to a preparation method of the Chinese medicine compound. The Chinese medicine compound of the present invention has the effects of reinforcing the spleen and replenishing qi, removing heat and toxic substance, promoting diuresis and eliminating dampness, nourishing liver and kidney, etc., which is used for curing such symptoms as a large amount of albuminuria, serious edema, hypoproteinemia and hyperlipidemia caused by nephropathy syndrome.
Owner:BEIJING ZHONGTAI TIANHE SCI & TECH
Leave of glutinous rehmannia extractive, its prepn. method and use, medicines prepd. with said extractives
ActiveCN1947757ASignificant effectAlleviate the contradiction between supply and demandUrinary disorderPlant ingredientsDiseaseMedicine
An extract of rehmannia leaf used for preparing the medicines and health-care food to prevent and treat the renal function diseases, such as albuminuria, hematuria, chronic glomerulonephritis is disclosed. Its preparing process is also disclosed.
Owner:SICHUAN MEDCO PHARML
Novel uses of bisbenzylisoquinoline alkaloid derivative or analogue of general formula I
InactiveCN102657652ARestore mechanical propertiesRestoring the Charge BarrierOrganic active ingredientsUrinary disorderTherapeutic effectDiabetic nephropathy
The invention provides a use of a bisbenzylisoquinoline alkaloid derivative or analogue to prepare medicine medicines for treating diabetic nephropathy. The bisbenzylisoquinoline alkaloid derivative of general formula I provided by the invention by relieving glomerular basement membrane thickening, reduces foot process fusion of glomerular epithelial cells and restores mechanical barrier and charge barrier of glomerulus, thus reducing protein leakage, having a good therapeutic effect on diabetic nephropathy (stage III or stage IV) patients, reducing 24h micro-albumin (UAE) and 24h urine protein (UPQ), having a good inhibitory effect on the albuminuria symptom of the diabetic nephropathy, and providing a new choice for the clinical treatment of the diabetic nephropathy.
Owner:李宏
Chinese medicinal composition for treating kidney failure diseases and preparation method thereof
InactiveCN101810792AImprove self-coordinationFunction increaseUrinary disorderAluminium/calcium/magnesium active ingredientsNervous systemAdemetionine
The invention discloses a novel Chinese medicinal composition for treating kidney failure diseases and a preparation method thereof. The Chinese medicinal composition mainly comprises the following raw material medicaments: medlar, American ginseng, campanumaea pilosula, raw astragalus, pantotrichum, common yam rhizome, sea horse, medicinal indianmulberry root, cordyceps sinensis, lucid ganoderma, south dodder seed, gordon euryale seed, eucommia bark, radix rehmanniae preparata, Chinese angelica, white paeony root, cochinchnese asparagus root, glossy privet fruit, amur corktree bark, Indian buead, gardenia, plantain seed, longhairy antenoron herb, talc and oriental waterplantain rhizome. The Chinese medicinal composition can be prepared into any common oral preparation by the conventional Chinese medicinal preparation method. The Chinese medicinal composition can obviously improve symptoms such as edemaofface, edema of limbs, inability to get food down, bradypsychia, uroschesis, creatinine, albuminuria, dreaminess, insomnia and the like, and can improve various complications which seriously influence health and life and even cause depth such as infection, diseases of cardiovascular systems, nervous systems and digestive systems, electrolyte disturbance, metabolic acidosis and the like caused by renal function hydrolysis. The Chinese medicinal composition has the advantages of exact clinical effects, obvious curative effect, quick response, low cost, basically no toxic or side effects and the like because the Chinese medicinal composition basically combines medicaments having homology of medicament and food specified in national formulary.
Owner:TAIYI HEPU BEIJING RES INST OF TCM
Methods and compositions for characterizing patients for clinical outcome trials
InactiveUS20100136540A1Prevent and treat and reduce riskReduced activityMetabolism disorderMicrobiological testing/measurementClinical trialTandem repeat
The invention provides with methods for characterizing and selecting, within a population of subjects with type-2 diabetes, subjects that are suited for clinical trials based on the identification of one or more genetic features, which are single nucleotide polymorphisms (SNPs), short tandem repeats (STRs), and / or other genomic markers. The invention further involves characterizing these subjects based on the probability of developing complications related to type-2 diabetes, such as, myocardial infarction, stroke and albuminuria. Also described are combinations and kits for carrying out the above-described methods.
Owner:PROGNOMIX INC
Chinese medicinal compound preparation for treating IgA (Immunoglobulin A) nephropathy and preparation method thereof
InactiveCN102370798ASignificant effectEliminate side effectsAnthropod material medical ingredientsUrinary disorderSalvia miltiorrhizaSide effect
The invention relates to a compound Chinese medicinal preparation for treating IgA (Immunoglobulin A) nephropathy. The compound Chinese medicinal preparation comprises the following Chinese medicinal raw materials by weight: 13-17 grams of astragalus, 8-12 grams of rehmannia root, 8-12 grams of red-rooted salvia root, 8-12 grams of common bletilla pseudobulb, 2-4 grams of cicada shell, 8-12 grams of garden burnet root, 16-24 grams of cogongrass rhizome and 2-4 grams of Chinese caterpillar fungus (brewed). A preparation method of the compound Chinese medicinal preparation comprises the following steps of: cleaning the eight types of medicinal materials; mixing proportionally; adding water in an amount which is 6-8 times the total weight of the medicinal materials or 70 percent by volume of ethanol for decocting for three times, every time for 40 minutes; combining decoction solutions obtained in the three times; filtering; and concentrating to obtain a liquid extract of which the specific weight is 1.21 at 60 DEG C. The compound Chinese medicinal preparation can be prepared into any pharmaceutical dosage form, such as tablets, capsules, granules, oral liquid, pills and syrup with the conventional preparation process. The compound Chinese medicinal preparation prepared with the method has the advantages of great reduction in the concentrations of albuminuria and hematuria of patient suffering from IgA nephropathy, great improvement on the kidney function, remarkable curative effect and great reduction in side effects and untoward reactions.
Owner:INST OF BASIC RES & CLINICAL MEDICINE CHINA ACAD OF CHINESE MEDICAL SCI
Chinese medicinal composition for treating renal cyst diseases and preparation method thereof
InactiveCN101810823AAchieve standardizationAchieve scaleAnthropod material medical ingredientsUrinary disorderDiseaseAmnesia
The invention discloses a novel Chinese medicinal composition for treating renal cyst diseases and a preparation method thereof. The Chinese medicinal composition mainly comprises the following raw material medicaments: mix-fried pangolin scales, tangerine peel, Chinese angelica, immature bitter orange, common burreed rhizome, zedoary, turmeric root-tuber, peach seed, safflower, turtle shell, tortoise plastron, Szechuan lovage rhizome, red paeony root, dragon's blood, Chinese eaglewood, green tangerine peel, root of red-rooted salvia, Indian buead, oriental waterplantain rhizome, cortex lycii radicis, amur corktree bark, gardenia, Vietnamese sophora root, raw rehmannia root, liriope, coridius, nutgrass galingale rhizome, medicated leaven and plantain seed. The Chinese medicinal composition can be prepared into any common oral preparation by the conventional Chinese medicinal preparation method. The Chinese medicinal composition can obviously improve symptoms such as renal cyst, polycystic kidney, extensive abdominal edema, uroclepsia, hematuria, albuminuria, urinary tract infection, malaise, loss of appetite, dreaminess, insomnia, amnesia and the like. The Chinese medicinal composition has the advantages of exact clinical effects, obvious curative effect, quick response, low cost, basically no toxic or side effects and the like because the Chinese medicinal composition basically combines medicaments having homology of medicament and food specified in national formulary.
Owner:TAIYI HEPU BEIJING RES INST OF TCM
Use of vasopeptidase inhibitors in the treatment of metabolic diseases, nephropathy and advanced glycation end-product associated diseases
The invention describes and claims the use of vasopeptidase inhibitors of formula (I) for the treatment of nephropathy in diabetic or non-diabetic patients, including diabetic or non-diabetic nephropathy, glomerulonephritis, glomerular sclerosis, nephrotic syndome, hypertensive nephrosclerosis, microalbuminuria or end stage renal disease, or insulin resistance or of metabolic diseases associated with advanced glycation end-products, such as diabetic complications, diabetic neuropathy, diabetic nephropathy, diabetic retinopathy, cataracts, myocardial infarction and / or diabetic cardiomyopathy, or atherosclerosis or endothelial dysfunction.
Owner:SANOFI AVENTIS DEUT GMBH
Novel use of penthorum chinense pursh in prevention and treatment of renal albuminuria
The invention aims to provide a novel use of penthorum chinense pursh and medicine or health care food prepared from the penthorum chinense pursh, and particularly relates to the novel use of the penthorum chinense pursh and the medicine or health care food prepared from the penthorum chinense pursh in the prevention and treatment of renal albuminuria. Tests show that the penthorum chinense purshhas an effect of reducing urinary proteins of nephropathy. According to the novel use, the application scope of the penthorum chinense pursh is enlarged, and a basis is provided for the clinical application of the penthorum chinense pursh in the prevention and treatment of the renal albuminuria.
Owner:SOUTHWEST MEDICAL UNIVERISTY
Capsule for treatment of nephrotic syndrome
The invention discloses a capsule for treatment of nephrotic syndromes, which is prepared with the modern process for processing and refining of raw materials required in the prescription with nine kinds of traditional Chinese herbs, including radix codonopsitis, Astragalus root, prepared rhizome of rehmannia, angelica, American ginseng, phellodendron, Tuckahoe, safflower and peach kernel. The capsule in the invention has the functions of supplementing qi, nourishing yin, clearing away pathogenic heat and removing dampness, and can be used for treatment of nephrotic syndromes, particularly for treatment of nephrotic syndromes with a large amount of albuminuria as the main clinical feature. Based on the pharmacodynamic test and study, the invention can significantly reduce the urokinase protein, blood urea nitrogen and creatinine of animals in the nephrosis model, improve the hematoglobin, ease the pathological lesion of kidney tissues, and promote or quicken the structural recovery of the kidney tissues. The results show that the capsule has significant therapeutic effect on the nephrotic syndromes.
Owner:BEIJING ZHONGKE RENHE SCI & TECH
Bag tea for treating diabetes and preparing process
InactiveCN101401602APromote secretionStimulation of increased secretionPre-extraction tea treatmentMetabolism disorderTrace elementBlood sugar
The invention relates to a teabag for curing diabetes, which is prepared from 90 to 95 percent of Pu'er Tea and 5 to 10 percent of amino acid concentrated solution. Because the Pu'er tea of the product contains rich trace elements, the Pu'er Tea has positive action on the prevention and reduction of complication of diabetes together with the amino acid, thereby improving and controlling blood sugar and the blood pressure, adjusting the blood-fat and improving the albuminuria.
Owner:李慧贞
Glomerulus on a chip to recapitulate glomerular filtration barrier
PendingUS20200354663A1Bioreactor/fermenter combinationsBiological substance pretreatmentsAutoantibodyProtein
A glomerulus on a chip (GOAC) to recapitulate the human glomerular filtration barrier, the structure responsible for filtering the blood and preventing the loss of proteins, is provided using human podocytes and glomerular endothelial cells seeded into microfluidic chips. In long-term cultures, cells maintain their morphology, form capillary-like structures and express slit diaphragm proteins. This system recapitulates functions and structure of the glomerulus, including permselectivity. When exposed to sera from patients with anti-podocyte autoantibodies, the chips show albuminuria proportional to patients' proteinuria, phenomenon not observed with sera from healthy controls or individuals with primary podocyte defects. Also shown is its applicability for renal disease modeling and drug testing.
Owner:CHILDRENS HOSPITAL OF LOS ANGELES
Treatment of renal injury
Methods for the treatment of renal injury include the use of arginase inhibitors in the treatment and prevention of diabetic nephropathy, albuminuria and azotemia amongst others, and methods for identifying agents for the treatment of renal injury.
Owner:PENN STATE RES FOUND
Traditional Chinese medicine composition for treating child nephritis and nephropathy
InactiveCN105250769ALow costReasonable formulaUrinary disorderPlant ingredientsMedicinal herbsMarked effect
The invention discloses a traditional Chinese medicine composition for treating child nephritis and nephropathy. The traditional Chinese medicine composition is prepared from the following raw materials in parts by weight: 25-35 parts of common achyranthes herb, 13-17 parts of heartleaf houttuynia herb, 13-17 parts of barbed skullcap herb, 13-17 parts of motherwort herb, 13-17 parts of plantain herb, 25-35 parts of lalang grass rhizome and 1-2 parts of common rush. The traditional Chinese medicine composition disclosed by the invention adopts multiple Chinese medicinal herbs in compatibility, is low in cost, reasonable in formula and good in drug effect exertion, does not have side effects, and has the effects of clearing away heat and toxic materials, inducing dieresis to excrete dampness, promoting blood circulation, lowering blood pressure and the like. The traditional Chinese medicine composition has a marked effect in treating child acute and chronic nephritis, nephrotic syndromes and urinary system infection, including the symptoms of edema, hematuria, albuminuria, hypertension, general malaise, hypodynamia, inappetence, fever, headache, dizziness, cough, vomiting, abdominal pains and the like. A clinical pharmacodynamic test proves that the cure rate of the traditional Chinese medicine composition for treating the child nephritis and nephropathy reaches 66% and the total effective rate is close to 100%.
Owner:安徽益健堂中药饮片科技有限公司
Chinese meidine composition for treating nephritis dropsy and use thereof
InactiveCN1814193AGood treatment effectGood curative effectUrinary disorderPill deliverySide effectLiver and kidney
The invention discloses a Chinese medicinal combination for curing nephritis and edema and the application thereof, composed of Chinese Brake Herb, Jixuecao, Liquoricee Root, Persimmon Leaf, Membranous Milkvetch Root, Plantain Herb, etc. It is to be orally taken, convenient to use, tasting good and easy to be accepted by patients; has functions of nourishing liver and kidney, promoting blood circulation and rmoving blood stasis, and causing diuresis and detumescence, having advantages of good curative effect, short period of treatment, low price, no toxicity and side effect, convenient for patients to take, etc; and it is an ideal effective medicine for patients with acute and chronic nephritis and edema, hematuria, and albuminuria to select.
Owner:杨雄志
Drugs for the treatment of chronic kidney disease with excessive dampness and heat
ActiveCN102283980AReduce leakageReduce aggregationAnthropod material medical ingredientsUrinary disorderBarbed Skullcap HerbSide effect
The invention relates to a pure Chinese medicament for treating chronic kidney disease, in particular to a medicament for treating damp and heat swelling type chronic kidney disease, which solves the problems of great side effect and little treatment effect for the traditional medicament for treating the chronic kidney disease. The medicament is prepared from the following raw materials of Chinese angelica, divaricate saposhnikovia root, fructus schisandrae chinensis, gordon euryale seed, mantis egg-case, herba pogostemonis, capillary wormwood herb, barbed skullcap herb, spreading hedyotis herb, Japan yam rhizome, herba pyrrosiae, rhizome chuangxiong, achyranthes, grassleaf sweelflag rhizome, sevenlobed yam rhizome, dried orange peel, liquorice and polyporus umbellatus. By mixing various raw materials, the medicament has the efficacy for albuminuria patients suffered from heat swelling type chronic kidney disease and obtained favorable curative effects for protecting kidney functions.In addition, the medicament has the advantages of safety, reliability, no side effect, short treatment course, low relapse, low cost, favorable economic and social benefits as well as favorable development and application prospect.
Owner:SHANXI PROVINCE CHINESE MEDICINE RES INST
Urinary albumin/urinary creatinine composite quality control product and production method thereof
PendingCN112858690AReduce degradationPrevent oxidation precipitationBiological testingFlufenamic acidDextran
The invention provides a urinary albumin / urinary creatinine composite quality control product and a production method thereof. The urinary albumin / urinary creatinine composite quality control product comprises the following components: 50-100 mmol / L of a buffer solution, 5-15 g / L of salt, 5-15 g / L of flufenamic acid, 5-15 g / L of dimethyl sulfoxide, 5-15 g / L of a reducing agent, 5-15 g / L of dextran, 5-15 g / L of a defoaming agent; 0.5-1 g / L of a tackifier, 100-200 mg / L of human serum albumin, 10-20 mmol / L of creatinine, and 1 g / L of a preservative. A pH value of the quality control product is 7.2-7.4. The product can be used for evaluating the accuracy of the urinary albumin / urinary creatinine detection reagent based on a microfluidic technology, and plays an important role in guaranteeing the laboratory detection result quality of the urinary albumin / urinary creatinine detection reagent and reducing errors.
Owner:NINGBO POLYTECHNIC
Determination of risk for development of cardiovascular disease by measuring urinary levels of podocin and nephrin messenger RNA
A method for a determining of risk for development of cardiovascular disease by measuring levels of the at least gene of interest is disclosed. The method may identify subjects with moderate albuminuria and diagnosis or predict cardiovascular disease several years before either of these outcomes is detectable by present methodologies.
Owner:AMERICAN UNIVERSITY OF BEIRUT
Decoction capable of nourishing kidney, promoting recovery, and eliminating albuminuria
The invention discloses a decoction capable of nourishing kidney, promoting recovery, and eliminating albuminuria, especially provides a traditional Chinese medicine composition used for treating chronic nephrosis and eliminating albuminuria, and a preparation method thereof, and belongs to the field of traditional Chinese medicine preparation. The traditional Chinese medicine composition is composed of following traditional Chinese medicine raw materials: radix astragali, radix codonopsis, rhizoma atractylodis macrocephalae, poria cocos, coix seeds, cornus officinalis, eucommia ulmoides, fructus rosae laevigatae, semen euryales, rhizoma smilacis glabrae, herba houttuyniae, ligustrum lucidum, eclipta, radix salviae miltiorrhizae, radix paeoniae rubra, fructus amomi, pericarpium citri reticulatae, ageratum cornyzoides, raw dragon bone, raw concha ostreae, pyrrosia lingua, and lalang grass rhizome. The traditional Chinese medicine composition is capable of nourishing kidney, tonifying spleen, and clearing heat and draining dampness.
Owner:王宝军 +1
Medicine for treating nephritis combined with a great amount of albuminuria and respiratory tract infection
InactiveCN102397386AQuick resultsGood curative effectAnthropod material medical ingredientsUrinary disorderTherapeutic effectAchyranthes
The invention relates to a medicine for treating nephritis combined with a great amount of albuminuria and respiratory tract infection, which is made of epimedium, herba pyrrosiae, cooked aconite, oldenlandia diffusa, rhizoma ligustici wallichii, angelica, teasel root, cicada ecdysis, radix achyranthis bidentatae, forsythia, Radix Rhapontici seu Radix Echinopsis, pangolin, radix morindae officinalis, Chinese Polyphaga and ordate houttuynia, the raw materials are added into water to be decocted into decoction, one dose of the decoction is taken every day, every 15 days count a period of treatment, and the syndrome can be alleviated generally after the decoction is taken for 2 to 3 periods of treatment. The medicine is antifatigue and can dredge muscle and vessel, treatment effect on nephritis combined with a great amount of albuminuria and respiratory tract infection is remarkable, and the general effective rate can reach 98.1 percent.
Owner:句文宝
Chinese medicament for treating chronic nephritis
InactiveCN101979058APromote circulationNo side effectsUrinary disorderPlant ingredientsBarbed Skullcap HerbPumpkin seed
The invention belongs to a Chinese medicinal composition, and particularly relates to a Chinese medicament for treating chronic nephritis. The Chinese medicament is prepared from the following raw materials in part by weight: 2 to 4 parts of willow-leaved smartweed, 10 to 12 parts of finger citron, 4 to 6 parts of rangoon-creeper fruit, 2 to 4 parts of chinaberry bark, 4 to 6 parts of pumpkin seed, 2 to 4 parts of bud of hairyvein agrimony, 2 to 4 parts of apocynum, 5 to 10 parts of motherwort, 5 to 10 parts of root of red rooted salvia, 5 to 10 parts of astragalus, 4 to 6 parts of many-flower solomonseal rhizome, 5 to 10 parts of tuckahoe, 2 to 4 parts of dodder seed, 3 to 5 parts of barbed skullcap herb, 2 to 4 parts of pharbitis seed and 3 to 6 parts of reed root. The Chinese medicament has the advantages of no toxic or side effect, good treatment effect, low cost, simple preparation method and convenience for administration, has the effects of activating blood, dissolving stasis, relieving heat, easing pain, promoting urination and diminishing swelling, and has good effect of treating chronic nephritis edema, hematuria and albuminuria, dredging meridians, improving blood circulation, detoxifying, dissolving stasis, diminishing swelling, promoting urination, tonifying kidney, tonifying spleen and enhancing kidney function.
Owner:姜秀芹
Chinese medicinal preparation for treating proteinuria caused by diabetic nephropathy and preparation method thereof
InactiveCN100534486CIncrease blood flowControl infiltrationPowder deliveryAnthropod material medical ingredientsBroom RapeMyrrh
Disclosed is a Chinese medicinal preparation for treating diabetes, nephropathy and albuminuria, and the process for preparation, wherein the constituents include astragalus root, wolferry fruit, Chinese angelica root, earthworm, frankincense, myrrh, dried body of ground beetle, motherwort, plantain seeds, oriental water plantain rhizome, sweet basil, pilose asiabell root, broomrape, dipsacus root, poria cocos and rhizoma dioscoreae.
Owner:李辉
Medicine for treating nephropathy and preparation method thereof
InactiveCN102018893ADilated blood vesselsImprove immunityUrinary disorderPlant ingredientsSide effectImmune complex deposition
The invention belongs to the technical field of traditional Chinese medicine, in particular to a medicine for treating nephropathy and a preparation method thereof, wherein the nephropathy comprises acute and chronic nephritis, nephritic syndrome or early-stage uremia. The traditional Chinese medicine is prepared from the following pharmaceutical raw materials in parts by weight: 10-60 parts of radix astragali, 6-15 parts of angelica, 6-15 parts of rhizoma gastrodiae, 3-6 parts of plantain seed, 6-15 parts of black mushroom and 0.5-3 parts of aweto. The medicine provided by the invention decomposes immune complexes by improving the immunity and activating complements, dilates the blood vessels of the kidneys, nourishes the kidney cells, reduces the albuminuria and hematuria, promotes urination, decreases swelling, defecates, and eliminates toxicant, thereby achieving the purpose of treating both principal and secondary aspects of disease without side effects.
Owner:丁德政
Chinese medicament for treating chronic nephritis
InactiveCN101979058BPromote circulationNo side effectsUrinary disorderPlant ingredientsBarbed Skullcap HerbSide effect
The invention belongs to a Chinese medicinal composition, and particularly relates to a Chinese medicament for treating chronic nephritis. The Chinese medicament is prepared from the following raw materials in part by weight: 2 to 4 parts of willow-leaved smartweed, 10 to 12 parts of finger citron, 4 to 6 parts of rangoon-creeper fruit, 2 to 4 parts of chinaberry bark, 4 to 6 parts of pumpkin seed, 2 to 4 parts of bud of hairyvein agrimony, 2 to 4 parts of apocynum, 5 to 10 parts of motherwort, 5 to 10 parts of root of red rooted salvia, 5 to 10 parts of astragalus, 4 to 6 parts of many-flower solomonseal rhizome, 5 to 10 parts of tuckahoe, 2 to 4 parts of dodder seed, 3 to 5 parts of barbed skullcap herb, 2 to 4 parts of pharbitis seed and 3 to 6 parts of reed root. The Chinese medicament has the advantages of no toxic or side effect, good treatment effect, low cost, simple preparation method and convenience for administration, has the effects of activating blood, dissolving stasis, relieving heat, easing pain, promoting urination and diminishing swelling, and has good effect of treating chronic nephritis edema, hematuria and albuminuria, dredging meridians, improving blood circulation, detoxifying, dissolving stasis, diminishing swelling, promoting urination, tonifying kidney, tonifying spleen and enhancing kidney function.
Owner:姜秀芹
Chinese medicinal preparation for treating proteinuria caused by diabetic nephropathy and preparation method thereof
InactiveCN1951457AIncrease blood flowControl infiltrationPowder deliveryAnthropod material medical ingredientsBroom RapeMyrrh
Disclosed is a Chinese medicinal preparation for treating diabetes, nephropathy and albuminuria, and the process for preparation, wherein the constituents include astragalus root, wolferry fruit, Chinese angelica root, earthworm, frankincense, myrrh, dried body of ground beetle, motherwort, plantain seeds, oriental water plantain rhizome, sweet basil, pilose asiabell root, broomrape, dipsacus root, poria cocos and rhizoma dioscoreae.
Owner:李辉
Traditional Chinese medicine preparation for treating pneumonia infected with novel coronaviruses
InactiveCN111671832AAvoid damageReduce exudateAntiviralsUnknown materialsLicorice rootsWolfiporia extensa
The invention discloses a traditional Chinese medicine preparation for treating pneumonia infected with novel coronaviruses. The preparation adopting the formula comprises the components in parts by mass of 15-25 parts of polyporus umbellatus, 15-60 parts of poria cocos, 15-25 parts of rhizoma alismatis, 10-20 parts of talc, 10-20 parts of rhizoma coptidis, 15-25 parts of tree peony bark, 6-30 parts of apricot kernels, 10-20 parts of colla corii asini and 15-25 parts of licorice roots. The traditional Chinese medicine preparation for treating pneumonia infected with novel coronaviruses can realize target effects on human cell surface ACE2 receptors, and can block a way that the novel coronaviruses invade organisms, so that the traditional Chinese medicine preparation has the effects of preventing and treating clinical situation of the novel coronaviruses. The traditional Chinese medicine preparation for treating pneumonia infected with novel coronaviruses has obvious and quick improvement effects on symptoms of fever, dry cough, weakness, chest pain and the like, can reduce blood pressure, alleviate oedematous and has special effects on patients suffering from albuminuria and renalfunction damage through laboratory examination.
Owner:王相钧
Application of cobra neurotoxin polypeptide molecules to treatment of nephritis albuminuria
PendingCN110755603AReduced autoimmune responseAlleviate pathological changesPeptide/protein ingredientsUrinary disorderDisease courseAutoimmunity
After a nephritis patient suffers from nephritis for several years, albumin in a little blood begins to leak into urine, at the moment, albumin leakage is easy to neglect because clinical symptoms arenot significant or the albumin is confused with other albuminuria caused by hypertension and hyperlipaemia, so that the illness state is worsened. But when it is found that other indexes reflecting renal functions, such as [beta]2 microglobulin, [alpha]1 microglobulin, transferrin and immunoglobulin are also obviously increased in urine, the situation confirms that the renal functions already have pathology changes. At present, no other effective methods exist except hormone on treatment, but long-term hormone treatment can cause many side reactions to the patient. If illness course freely develops, more albumin leaks into urine, and kidney damage can be further worsened. Cobra neurotoxin polypeptide molecules can effectively reduce leak of various albumin in urine, control and delay kidney pathologic progress, improve renal functions and have important significance in treatment of the nephritis through restraining autoimmunity inflammatory reactions of the kidney.
Owner:祁展楷
Leave of glutinous rehmannia extractive, its preparation method and use, medicines prepared with said extractives
ActiveCN1947757BSignificant effectAlleviate the contradiction between supply and demandUrinary disorderPlant ingredientsDiseaseAdditive ingredient
An extract of rehmannia leaf used for preparing the medicines and health-care food to prevent and treat the renal function diseases, such as albuminuria, hematuria, chronic glomerulonephritis is disclosed. Its preparing process is also disclosed.
Owner:SICHUAN MEDCO PHARML
Medicament for treating cirrhosis ascites and hepatorenal syndrome and preparation method thereof
InactiveCN101347573BImprove clearanceRestore filter functionMammal material medical ingredientsPlant ingredientsDiseasePinellia
Owner:杨春元
Chinese medicinal composition for treating renal cyst diseases and use of preparing medicine
InactiveCN101810823BImprove self-coordinationEffective treatmentAnthropod material medical ingredientsUrinary disorderAmnesiaDisease
The invention discloses a novel Chinese medicinal composition for treating renal cyst diseases and a preparation method thereof. The Chinese medicinal composition mainly comprises the following raw material medicaments: mix-fried pangolin scales, tangerine peel, Chinese angelica, immature bitter orange, common burreed rhizome, zedoary, turmeric root-tuber, peach seed, safflower, turtle shell, tortoise plastron, Szechuan lovage rhizome, red paeony root, dragon's blood, Chinese eaglewood, green tangerine peel, root of red-rooted salvia, Indian buead, oriental waterplantain rhizome, cortex lyciiradicis, amur corktree bark, gardenia, Vietnamese sophora root, raw rehmannia root, liriope, coridius, nutgrass galingale rhizome, medicated leaven and plantain seed. The Chinese medicinal composition can be prepared into any common oral preparation by the conventional Chinese medicinal preparation method. The Chinese medicinal composition can obviously improve symptoms such as renal cyst, polycystic kidney, extensive abdominal edema, uroclepsia, hematuria, albuminuria, urinary tract infection, malaise, loss of appetite, dreaminess, insomnia, amnesia and the like. The Chinese medicinal composition has the advantages of exact clinical effects, obvious curative effect, quick response, low cost, basically no toxic or side effects and the like because the Chinese medicinal composition basically combines medicaments having homology of medicament and food specified in national formulary.
Owner:TAIYI HEPU BEIJING RES INST OF TCM
Who we serve
- R&D Engineer
- R&D Manager
- IP Professional
Why Patsnap Eureka
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com